Pharmaceutical and biotech businesses were enthusiastic about the UPC before the court opened, but so far there has only been ...

Dec. 6, 2024 — BK polyomavirus, or BKPyV, is a major cause of kidney transplant failure. There are no effective drugs to treat BKPyV. Research reveals new aspects of BKPyV replication, offering ...

Recursion Pharmaceuticals is reshaping drug discovery with AI, strategic partnerships, and financial discipline for long-term ...

Chronic pain casts a long shadow, impacting millions globally. While medications offer some relief, they often come with drawbacks. Enter non-pharmacological treatments like exercise, meditation, ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

As President-elect Trump prepares for his second term in office, the health care industry is poised for a period of potential ...

We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a ...

Teva Pharmaceutical Industries Ltd (TEVA ... or 15% in local currency terms, compared to Q3 2023.AUSTEDO® – shows continued growth, U.S. revenues of $435 million in Q3 2024, an increase ...

After hours: December 11 at 4:48:39 PM EST Loading Chart for RARE ...

In addition to efforts to reduce dependence on raw material imports, the government has prepared a roadmap to accelerate the development of the pharmaceutical industry. The long-term goal is to ...